The Lancet21h
Management of hepatocellular carcinoma
Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...
Hartford Courant5d
CT senior living campus plans second major expansion in 3 years. Here’s how many units could be added
If it’s approved, this would be McLean’s second major expansion in three years ... to our existing senior living options. A second phase of expansion was always anticipated.
News Medical on MSN1d
New 3D tissue imaging technique enhances thyroid tumor analysis
Empa researchers have developed a new 3D tissue analysis for thyroid tumors. This special X-ray technique uses artificial ...
asco.org5d
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma (HCC).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...